This report presents a structured performance and profitability analysis of a multi-country pharmacy retail business. The analysis is organized into four progressive layers: overall performance overview, geography and product performance, promotion and margin optimization, and strategic business actions. Key findings highlight strong structural profitability of approximately 28% gross margin, revenue concentration in major European markets, and margin compression from promotions, which reduce margins by about 9 percentage points and result in an estimated €82K annual margin loss without significant volume lift. Price realization remains high at around 97%, indicating strong pricing discipline. Overall, the report delivers financially grounded, actionable recommendations beyond descriptive analytics.